In 2022, our first planetary defense test mission, the Double Asteroid Redirection Test (DART), will attempt to change the motion of a small moonlet, Dimorphos, that poses no threat to Earth. This demonstration, led by the JHU Applied Physics Laboratory (APL), will test a new asteroid deflection technology: www.nasa.gov/dart
Innovating And Investing In The New Space Age — Space 2.0 — Hélène Huby, VP, Orion-ESM, Airbus Defence and Space.
Hélène Huby is Vice-President of the Orion European Service Module (Orion-ESM), at Airbus Defence & Space.
A pair of researchers from Toho University and NASA Nexus for Exoplanet System Science has found evidence, via simulation, that Earth will lose its oxygen-rich atmosphere in approximately 1 billion years. In their paper published in the journal Nature Geoscience, Kazumi Ozaki and Christopher Reinhard describe the factors that went into their simulation and what it showed.
Dr. John Torday, Ph.D. is an Investigator at The Lundquist Institute of Biomedical Innovation, a Professor of Pediatrics and Obstetrics/Gynecology, and Faculty, Evolutionary Medicine, at the David Geffen School of Medicine at UCLA, and Director of the Perinatal Research Training Program, the Guenther Laboratory for Cell-Molecular Biology, and Faculty in the Division of Neonatology, at Harbor-UCLA Medical Center.
Dr. Torday studies the cellular-molecular development of the lung and other visceral organs, and using the well-established principles of cell-cell communication as the basis for determining the patterns of physiologic development, his laboratory was the first to determine the complete repertoire of lung alveolar morphogenesis. This highly regulated structure offered the opportunity to trace the evolution of the lung from its unicellular origins forward, developmentally and phylogenetically. The lung is an algorithm for understanding the evolution of other physiologic properties, such as in the kidney, skin, liver, gut, and central nervous system. Such basic knowledge of the how and why of physiologic evolution is useful in the effective diagnosis and treatment of disease.
NEW YORK—(BUSINESS WIRE)—Scientists at Applied Physics are excited to announce they have recently constructed the first model of physical warp drives.
“While we still can’t break the speed of light, we don’t need to in order to become an interstellar species” Tweet this
Applied Physics is an independent group of scientists, engineers, and inventors that advise companies and governments on science and technology for both commercial and humanitarian applications.
Researchers at the Technion-Israel Institute of Technology created a black hole analogue to confirm two of Hawking’s most important predictions, that Hawking radiation arises from nothing (it’s spontaneous) and its intensity does not change over time (it’s stationary).
Today, at a special AR/VR focused event held inside its virtual reality community platform Altspace, Microsoft showcased a new product aiming to provide their AR HoloLens platform and VR Windows Mixed Reality platform with a shared platform for meetings.
The app is called Microsoft Mesh and it gives users a cross AR/VR meeting space to interact with other users and 3D content, handling all of technical hard parts of sharing spatial multi-player experiences over the web. Like Microsoft’s other AR/VR apps, the sell seems to be less in the software than it is in enabling developers to tap into one more specialization of Azure, building their own software that builds on the capabilities. The company announced that AltspaceVR will now be Mesh-enabled.
In the company’s presentation, they swung for the fences in showcasing potential use cases, bringing in James Cameron, the co-founder of Cirque du Soleil and Pokémon Go developer Niantic.
Today, more than 90% of the indexed articles in the natural sciences are published in English. That wasn’t always the case.
In the search for ways to effectively combat age-related human disease, the enzyme sirtuin 6 (Sirt6) has recently become a focus of biochemical research. A targeted activation of Sirt6 could prevent or mitigate such diseases, for example some types of cancer. In a paper for the journal Nature Chemical Biology, biochemists from the University of Bayreuth have now shown how the small molecule MDL-801 binds to the enzyme Sirt6 and influences its activity. These findings stand to aid the development of new drugs.
